| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8746200 | Journal of Global Antimicrobial Resistance | 2018 | 18 Pages |
Abstract
C/T had good clinical responses in different types of infection, including both FDA-accepted and off-label indications. The results support the use of higher doses in RTIs.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Marc Xipell, Sandra Paredes, Leticia Fresco, Marta Bodro, Francesc Marco, J.A. MartÃnez, Alex Soriano,